Rapid antimicrobial susceptibility testing for gram-negative blood infections shows no improvement in clinical outcomes ...
The expanded panel includes 93 new microorganism-drug combinations, bringing the total panel size to 215, and in conformity with all the most current FDA breakpoints.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results